Operating Lease, Right-of-Use Asset of CUMBERLAND PHARMACEUTICALS INC from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CUMBERLAND PHARMACEUTICALS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • CUMBERLAND PHARMACEUTICALS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $7,570,452, a 22% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CUMBERLAND PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,570,452 +$1,362,041 +22% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $7,125,408 +$759,618 +12% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $7,177,490 +$656,402 +10% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $6,176,923 -$497,471 -7.5% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $6,208,411 -$502,744 -7.5% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $6,365,790 -$465,712 -6.8% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $6,521,088 +$1,602,031 +33% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $6,674,394 +$1,455,991 +28% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 $6,711,155 +$6,491,305 +2953% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $6,831,502 +$6,338,400 +1285% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $4,919,057 +$4,157,880 +546% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $5,218,403 +$4,194,203 +410% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $219,850 -$1,062,425 -83% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $493,102 -$1,042,454 -68% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $761,177 -$1,022,965 -57% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $1,024,200 -$1,003,948 -50% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q3 2021 $1,282,275 -$985,394 -43% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $1,535,556 -$967,294 -39% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $1,784,142 -$949,640 -35% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $2,028,148 -$932,421 -31% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 $2,267,669 -$779,614 -26% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q2
Q2 2020 $2,502,850 -$757,917 -23% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $2,733,782 -$754,195 -22% 31 Mar 2020 10-Q 22 May 2020 2019 Q1
Q4 2019 $2,960,569 +$2,960,565 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 $3,047,283 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $3,260,767 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $3,487,977 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $3.6* 01 Jan 2019 10-K 12 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.